Baker Bros. Advisors »

Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals Intl P Ord Shs Cl A (KNSA) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals Intl P Ord Shs Cl A held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $53M 2.8M 18.67

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeiGene Sponsored Adr (BGNE)
ACADIA Pharmaceuticals (ACAD)
Madrigal Pharmaceuticals (MDGL)
Revolution Medicines (RVMD)
Rhythm Pharmaceuticals (RYTM)
Insmed Incorporated Com Par $.01 (INSM)
Bicycle Therapeutics Sponsored Ads (BCYC)
Summit Therapeutics (SMMT)
Kymera Therapeutics (KYMR)
Edgewise Therapeutics (EWTX)
Alkermes SHS (ALKS)
Insmed Incorporated Note 0.75% 6/1/2028 (Principal)
Replimune Group (REPL)
Denali Therapeutics (DNLI)

View all positions for Baker Bros. Advisors

Top funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

BlackRock
Fairmount Funds Management
Hillhouse Capital Advisors
Baker Bros. Advisors
Rubric Capital Management
Braidwell
Morgan Stanley
State Street Corporation
Geode Capital Management
Nuveen Asset Management
Dimensional Fund Advisors
Rice Hall James & Associates
Parkman Healthcare Partners
Tang Capital Management
Millennium Management

View all funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A